- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Marlborough Today
By the People, for the People
Blackstone and TPG Complete $17B Acquisition of Hologic
Private equity firms take medical device maker private, name new CEO
Apr. 8, 2026 at 11:52am
Got story updates? Submit your updates here. ›
Blackstone and TPG have completed their $17 billion take-private acquisition of Hologic, a global medical technology company specializing in women's health. The deal will see Hologic delisted from the public markets, with the private equity firms naming Joe Almeida as the new CEO to lead the company under their ownership.
Why it matters
The acquisition of Hologic by Blackstone and TPG represents a major shift for the medical device maker, taking it out of the public eye and into private equity control. This could allow for more strategic flexibility, but also raises questions about the future direction of the company and its commitment to its existing product lines and markets.
The details
Under the terms of the deal, Hologic shareholders will receive $79 per share in cash, valuing the company at $17 billion. The transaction has now closed, with Hologic being delisted from the Nasdaq stock exchange. Blackstone and TPG have appointed Joe Almeida, the former chairman and CEO of Covidien, as the new CEO of Hologic to lead the company going forward.
- The acquisition was announced in January 2026.
- The deal closed on April 8, 2026.
The players
Hologic, Inc.
A global medical technology company specializing in women's health, including diagnostic products, imaging systems and surgical solutions.
Blackstone
A leading global investment firm that completed the $17 billion acquisition of Hologic.
TPG
A private equity firm that partnered with Blackstone on the Hologic acquisition.
Joe Almeida
The new CEO of Hologic, appointed by Blackstone and TPG to lead the company under private equity ownership.
What they’re saying
“We are excited to partner with the talented Hologic team to accelerate the company's growth and innovation in women's healthcare.”
— Joe Almeida, CEO, Hologic
What’s next
Hologic will now operate as a private company under the ownership of Blackstone and TPG, with a focus on expanding its product portfolio and market reach in the women's health sector.
The takeaway
The Hologic acquisition represents a significant shift in the medical device industry, with a prominent public company moving into private equity hands. This could allow for more strategic flexibility, but also raises questions about the long-term direction of the company and its commitment to its existing markets and stakeholders.
